Prospective Validation of a Predictive Model for Pathologic Complete Response After Chemoradiotherapy in Rectal Cancer: A Prognostic Study
The long-term research objective is to be able to select rectum cancer patients who could
receive a less invasive treatment. If prediction of response is possible, surgery may be
avoided when complete response after chemoradiotherapy is expected or performed with smaller
incisions if stage reduction is significant. This support decision system helps to
individualize patient treatment and can improve the quality of life for the patient.
Aim of the study
The main aim is to validate a predictive model for pathologic complete response (ypT0N0) in
rectal cancer patients treated with chemoradiotherapy by multi-centric prospective data
collection. The second aim is to collect extra data for improvement of the accuracy of the
prediction models with new variables. This new model will be validated later in the model
The validated accuracy of predictive models for pathologic complete response after
chemoradiotherapy in rectal cancer patients is high enough to tailor treatment
(surgery/non-surgery and/or administer extra radiation boosts) in clinical practice.
1. The performance of the developed models on the validation data is at least equal to the
performance achieved during the model development process.
2. The performance of a new model based on the addition of variables performs better than
the previous model
Observational Model: Case-Only, Time Perspective: Prospective
Pathological complete response (ypT0N0)
8-12 weeks after long-series chemoradiotherapy
Philippe Lambin, prof
Maastricht Radiation Oncology
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)